LNTHのチャート
LNTHの企業情報
| symbol | LNTH |
|---|---|
| 会社名 | Lantheus Holdings Inc （ランセウス・ホ―ルディングス） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: In Vitro_In Vivo Diagnostic Substances |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 ランテウス・ホールディングス(Lantheus Holdings Inc.)は臨床医が心臓血管と他の疾患の診断・治療を支援する診断用医用造影剤および製品の開発、製造、販売に従事している。同社の造影剤と製品は、心エコー検査および核撮像を含む、各イメージング様式にわたって使用される。同社は2つの事業区分を運営する。米国事業は米国内でその医療用イメージング剤および製品を製造、販売する。米国では、その製品をラジオファーマシ、統合配信ネットワーク、病院、診療所およびグループの実践に販売している。国際事業は、プエルトリコでの生産および流通活動とカナダでの直接販売活動で構成されている。9つの商品のポートフォリオは、各イメージング様式にわたって多様化している。その製品には、超音波造影剤および医療用放射性医薬品が含まれる。 ランセウス・ホ―ルディングスは米国の医療用イメ―ジング製品会社。診断医療イメ―ジング剤、心血管疾患および他の疾患診断で臨床医が使用する製品の開発、製造、販売に従事する。主に画像診断、心臓エコ―検査、分子イメ―ジング、MRIなどがあり、冠動脈疾患、うっ血性心不全、脳卒中、末梢血管疾患などの診断に定期的に使用される。本社はマサチュ―セッツ州。 Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB and an established leader and fully integrated provider of innovative imaging diagnostics, targeted therapeutics and artificial intelligence solutions to Find, Fight and Follow™ serious medical conditions. Lantheus provides a broad portfolio of products, including the echocardiography agent DEFINITY® Vial for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite® (Technetium Tc99m Generator), a technetium-based generator that provides the essential medical isotope used in nuclear medicine procedures; AZEDRA® for the treatment of certain rare neuroendocrine tumors; and RELISTOR® for the treatment of opioid-induced constipation, which is partnered with Bausch Health Companies, Inc. The Company is headquartered in North Billerica, Massachusetts with offices in New York, New Jersey, Canada and Sweden. |
| 本社所在地 | 331 Treble Cove Road North Billerica MA 01862 USA |
| 代表者氏名 | Mary Anne Heino メアリー・アン・ヘイノ |
| 代表者役職名 | President Chief Executive Officer Director 社長兼最高経営責任者（CEO） |
| 電話番号 | +1 978-671-8001 |
| 設立年月日 | 2007年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 2015年 |
| 従業員数 | 558人 |
| url | www.lantheus.com |
| nasdaq_url | https://www.nasdaq.com/symbol/lnth |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 73.28600 |
| 終値（lastsale） | 14.12 |
| 時価総額（marketcap） | 540794362.08 |
| 時価総額 | 時価総額（百万ドル） 517.04840 |
| 売上高 | 売上高（百万ドル） 329.38500 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 697.88540 |
| 当期純利益 | 当期純利益（百万ドル） 38.30800 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Lantheus Holdings Inc revenues decreased 1% to $168.2M. Net income increased 1% to $18M. Revenues reflect U.S. segment decrease of 2% to $145.6M. Net income reflects International segment income increase of 48% to $2.6M U.S. segment income increase of 1% to $28.4M. Basic Earnings per Share excluding Extraordinary Items decreased from $0.48 to $0.47. |
LNTHのテクニカル分析
LNTHのニュース
Truist Securities maintains Lantheus Holdings Inc at Buy with a price target of $125.00 2023/05/05 17:08:37 Investing.com
https://www.investing.com/news/pro/lantheus-holdings-inc-receives-investment-bank-analyst-rating-update-3074690
JMP Securities maintains Lantheus Holdings Inc at Market Outperform with a price target of $130.00 2023/05/05 06:53:37 Investing.com
https://www.investing.com/news/pro/lantheus-holdings-inc-receives-investment-bank-analyst-rating-update-3073977
Lantheus Holdings, Inc. (LNTH) Q1 2023 Earnings Call Transcript 2023/05/04 23:06:17 Seeking Alpha
Lantheus Holdings, Inc. (NASDAQ:NASDAQ:LNTH) Q1 2023 Results Conference Call May 4, 2023 8:00 AM ETCompany ParticipantsMark Kinarney - Vice President of Investor RelationsMary Anne Heino -…
Lantheus Holdings: Building A Sales Juggernaut 2023/05/04 19:43:07 Seeking Alpha
Lantheus Holdings reported stellar quarterly results once again for Q1 2023 and raised guidance significantly as well. Click here to read my earnings analysis of LNTH stock.
Stock Market Off Lows Ahead Of Apple And Jobs; Prostate Cancer Stock Jumps 15% After Earnings 2023/05/04 19:27:10 Investor''s Business Daily
Lantheus shares surged on positive buzz for their PET imaging detection agent for prostate cancer.
Analysts Predict A Surge In Lantheus Holdings Inc. (NASDAQ: LNTH)? 2022/12/31 12:00:00 Stocks Register
Lantheus Holdings Inc. (NASDAQ:LNTH) shares, rose in value on Friday, 12/30/22, with the stock price up by 0.67% to the previous day’s close as strong demand from buyers drove the stock to $50.96. Actively observing the price movement in the last trading, the stock closed the session at $50.62, falling within a range of $49.76 … Analysts Predict A Surge In Lantheus Holdings Inc. (NASDAQ: LNTH)? Read More »
POINT Biopharma Announces Closing of Agreements with Lantheus Holdings 2022/12/20 13:30:00 GlobeNewswire
INDIANAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. (“POINT”) (NASDAQ: PNT), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, today announced that the closing conditions, including Hart-Scott-Rodino antitrust clearance, have been met for the previously announced agreements with Lantheus Holdings Inc. (NASDAQ: LNTH).
Lantheus prices $500M convertible senior notes 2022/12/06 13:24:48 Seeking Alpha
Lantheus Holdings (LNTH) priced a $500M convertible senior notes due 2027.
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027 2022/12/06 12:45:00 GlobeNewswire
NORTH BILLERICA, Mass., Dec. 06, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the “Company” or “Lantheus”) (NASDAQ: LNTH), today announced the pricing of $500 million in aggregate principal amount of the Company’s convertible senior notes due 2027 (the “Notes”). The Notes are being sold only to persons reasonably believed to be “qualified institutional buyers” pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The Company also granted the initial purchasers of the Notes an option to purchase, within the 13-day period beginning on, and including, the initial closing date of the offering, up to an additional $75 million in aggregate principal amount of Notes. The sale of the Notes to the initial purchasers is expected to settle on or about December 8, 2022, subject to customary closing conditions, and is expected to result in approximately $485 million in net proceeds to the Company (assuming no exercise by the initial purchasers of their option to purchase additional notes), after deducting the initial purchaser’s discount and estimated offering expenses payable by the Company.
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating 2022/11/29 19:46:00 Investor''s Business Daily
Lantheus Holdings shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Lantheus Holdings Stock Showing Market Leadership; Earns 94 RS Rating 2022/11/29 19:46:00 Investor''s Business Daily
Lantheus Holdings shows improving price performance, earning an upgrade to its IBD Relative Strength Rating.
Lantheus: Sell Thesis Missing These Key Factors 2022/11/29 06:28:52 Seeking Alpha
Lantheus Holdings is a name we’ve scaled into this year and we’re here today to outline the findings of our risk/reward calculus. Read to learn more about LNTH.
LNTH stock up on approval for ultrasound enhancing agent in China (NASDAQ:LNTH) 2022/11/28 17:05:19 Seeking Alpha
U.S. healthcare supplier Lantheus Holdings, Inc. (LNTH) announced Monday that regulators in China approved an import drug license for its ultrasound-enhancing agent marketed as Definity
Lantheus Holdings: May Be Time To Buy After Big Correction (NASDAQ:LNTH) 2022/11/28 07:29:54 Seeking Alpha
Lantheus Holdings share price finally started to correct afer two years of continuous upward movement. Find out if LNTH stock has any gas left in the tank.
Lantheus Holdings Inc. (NASDAQ:LNTH) Drops -0.53%, But Further Rally Could Be Imminent 2022/11/26 21:00:00 Marketing Sentinel
In last trading session, Lantheus Holdings Inc. (NASDAQ:LNTH) saw 0.32 million shares changing hands with its beta currently measuring 0.76. Company’s recent per share price level of $58.45 trading at -$0.31 or -0.53% at ring of the bell on the day assigns it a market valuation of $3.84B. That closing price of LNTH’s stock is … Lantheus Holdings Inc. (NASDAQ:LNTH) Drops -0.53%, But Further Rally Could Be Imminent Read More »